CVS Pharmacy: Certifying the Diagnosis Without Checking the Records

In the CVS Medi-Cal settlement, CVS Pharmacy Inc. paid $18,282,280 to the United States and California to resolve allegations of billing for prescriptions without required diagnosis and documentation support. The pharmacy was supposed to confirm that patients met the program’s requirements for certain drugs. The government alleged that CVS certified qualifying conditions without doing the required checking. A pharmacist who knows what supported those certifications can see the difference between a prescription filled and a claim the program should pay.

A former CVS pharmacist started the qui tam case. It belongs among pharmaceutical fraud cases built on what a company told a public program to get paid. Here, the allegations concerned the pharmacy’s own claims and the conditions it certified.

Medi-Cal Code 1 Drugs Put the Diagnosis Behind the Payment

Medi-Cal Code 1 drugs carry diagnosis and documentation restrictions that the pharmacy must confirm. For certain drugs, the program pays only for approved diagnoses. A prescription for the drug therefore leaves a further question for the pharmacy: does the patient’s condition satisfy the restriction attached to payment?

Medi-Cal is California’s Medicaid health care program, administered by the California Department of Health Care Services and funded by both the federal and state governments. It serves people with low incomes and disabilities, among other Californians. Unsupported claims take taxpayer money from a healthcare program those patients rely on.

The Justice Department’s explanation of the drug restrictions identifies safety, effectiveness, potential misuse and cost as considerations in limiting reimbursement. The formulary, the program’s drug list, carries the restrictions. Pharmacies have the job of confirming and certifying that the drugs are dispensed for approved diagnoses.

For a prescription outside an approved diagnosis, CVS had to submit a request to the state justifying that use. The reason for prescribing the drug mattered to the payment decision. So did the pharmacy’s representation that it had checked.

What CVS Allegedly Certified to Medi-Cal

CVS allegedly submitted false electronic certifications stating that patients had medical conditions qualifying their prescriptions for Medi-Cal payment. California’s announcement places that conduct between 2010 and 2021. It alleges that CVS knowingly failed to verify or document required compliance for a large number of claims, resulting in millions of dollars in false payments.

The federal announcement describes the failure in terms a dispensing pharmacist would recognize. CVS allegedly failed to confirm and document the required diagnoses. In some instances, it allegedly dispensed drugs for nonapproved diagnoses and then knowingly billed Medi-Cal for those prescriptions. The settlement resolved allegations under both the federal and California False Claims Acts.

According to the government’s account, CVS certified that prescriptions qualified for payment while failing to do the work that supported that assurance. The alleged shortcut put the checking on paper without doing the checking.

For someone inside the pharmacy, the useful knowledge concerns that assurance: what information was available, what was actually checked, and what the company submitted for payment. Those are the decisions we would examine with an insider who recognizes the same practice.

CVS paid to resolve the claims without agreeing to federal compliance oversight through a corporate integrity agreement. The Department of Health and Human Services Office of Inspector General expressly noted that omission in the settlement announcement.

A Clinical Record and a Pharmacy Claim Can Tell Different Stories

The diagnosis can be present in a patient’s medical record without reaching the information captured when a pharmacy dispenses the drug. A 2018 Managed Care article on pricing drugs by indication describes that practical problem. It reports that some payers will struggle to identify the condition a drug treats because information in the clinical record might not be captured when the drug is dispensed.

The movement of medicine and the payment for it depend on different information. In the CVS allegations, the disputed connection was between dispensing the medicine and certifying that it qualified for Medi-Cal reimbursement. The clinical information gap described in Managed Care puts the pharmacy’s verification work at the center of that connection.

We would want to understand how diagnosis information reached the pharmacy, who handled the required confirmation, and how that work connected to the claim. A person familiar with the workflow can explain what a certification meant in practice.

What Are Red Flags for Pharmacists?

For pharmacists handling restricted-drug claims, a certification of a qualifying diagnosis without the required verification or documentation is the central red flag illustrated by the CVS allegations. Another is billing for a nonapproved diagnosis without the justification the program requires. Both concern the link between what the pharmacy knows and what it tells the payer.

When we assess a similar concern, we compare the prescription and diagnosis support with the certification and payment claim. Where the diagnosis falls outside the approved uses, the request and justification to the state become part of that comparison. The employee’s knowledge helps explain whether the claim reflected the work actually done.

Other Pharmacy Billing Cases Show the Same Gap

Other pharmacy cases show why the underlying transaction matters. In a separate Omnicare settlement announced in 2016, the government alleged that the company manually changed National Drug Codes when resubmitting rejected Medicare, Medicaid and TRICARE claims. The relevant comparison there was between the rejected claim and the drug code used when it was submitted again.

In the Walgreens settlement announced in 2024, the allegations concerned prescriptions processed but never picked up. The pharmacy’s processing record and the patient’s receipt of the medicine answered different questions. Across these cases, the useful comparison connects the claim to the event or condition that made payment possible: a qualifying diagnosis, the drug identified on a resubmission, or a prescription actually collected.

Can a Pharmacist Be a Whistleblower?

Yes. A former CVS pharmacist started this case, and the Justice Department said the pharmacist would receive approximately $3.3 million from the recovery.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

For a pharmacist considering a whistleblower case, the contribution can be explaining the distance between a written requirement and everyday practice. In a diagnosis-certification case, we work with the person who understands how the information was obtained, how the claim was prepared and where the required checking broke down. That knowledge gives the documents their meaning.

You Know What Supported the Certification

If you know that pharmacy claims certified diagnoses the required records did not support, speak to one of our whistleblower experts about how those claims were certified. We work with you to build your strongest whistleblower case and bring in pharmacy fraud whistleblower lawyers who understand diagnosis restrictions and government reimbursement. We stay beside you from your first account of the workflow through the pursuit of a recovery.